Clinical Trials Directory

Trials / Unknown

UnknownNCT04126122

Maternal and Neonatal Outcome in Severe Preeclampsia

Maternal and Neonatal Outcome in Severe Preeclamptic Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Aljazeera Hospital · Academic / Other
Sex
Female
Age
20 Years – 42 Years
Healthy volunteers
Accepted

Summary

In normal pregnancy the spiral arteries in the placental bed are invaded by trophoblast, which becomes incorporated into the vessel wall and replaces the endothelium, muscular layer and neural tissue

Detailed description

Preeclampsia is considered severe if one or more of the following: 1. Blood pressure of 160mmHg systolic or high or 110mmHg diastolic or high on two occasions at least 6 hours a part while the patient on bed rest. 2. Proteinuria of 0.3gm. or high in 24 hours urine specimen or +1 or great on two random urine samples collected at least 4 hours apart. 3. Oliguria of less than 500ml in 24 hours. 4. Cerebral or visual disturbance. 5. Pulmonary edema or cyanosis.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTUltrasonography to assess fetus and motherto assess fetal growth and maternal outcome

Timeline

Start date
2019-02-10
Primary completion
2020-01-10
Completion
2020-02-01
First posted
2019-10-15
Last updated
2019-10-15

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04126122. Inclusion in this directory is not an endorsement.